Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Completed 11Unknown 5Recruiting 5Active not recruiting 4Terminated 1Not yet recruiting 1

Sponsor Class

NIH 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Genitourinary 3Gynecologic 2Tumor-Agnostic 1

Conditions

Sarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 2Malignant mesenchymal tumor 1

Interventions

Doxorubicin 25Radiotherapy 16apatinib 15Cyclophosphamide 15Ifosfamide 13anlotinib 12camrelizumab 10Temozolomide 9Imatinib Mesylate 9Vincristine 8Surgical Procedures, Operative 7Neoadjuvant Therapy 7Methotrexate 7Drug Therapy 7Dactinomycin 5Blood Specimen Collection 5fludarabine phosphate 4Paclitaxel 4Immune Checkpoint Inhibitors 4Etoposide 4Docetaxel 4Carboplatin 4toripalimab 3pembrolizumab 3Trabectedin 3Topotecan 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Nivolumab 3Melphalan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Dactinomycin × Sarcoma × Clear all
NCT00020566 2014-06-24

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
1,200 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00002516 2013-09-17

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00245089 2013-08-12

Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
41 enrolled
Sarcoma

Sarcoma

NCT00245141 2013-08-12

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
32 enrolled
Sarcoma

Sarcoma

NCT00379457 2013-08-12

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
600 enrolled
Sarcoma

Malignant mesenchymal tumor, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡